How does masitinib help with ALS?

Masitinib is an experimental oral therapy being investigated in clinical trials as a potential treatment for amyotrophic lateral sclerosis (ALS). It works by blocking specific proteins called tyrosine kinases, which is expected to reduce the inflammation thought to be involved in ALS progression. In ALS clinical trials, the therapy helped to slow functional decline and significantly extended survival in a subgroup of patients.